Temsirolimus in women with platinum-resistant ovarian cancer or advanced/recurrent endometrial cancer: A multicenter phase II trial of the AGO Study Group (AGO-GYN 8).
Guenter Emons
No relevant relationships to disclose
Christian Kurzeder
No relevant relationships to disclose
Barbara Schmalfeldt
No relevant relationships to disclose
Alexander Reuss
No relevant relationships to disclose
Nikolaus de Gregorio
No relevant relationships to disclose
Jacobus Pfisterer
No relevant relationships to disclose
Tjoung-Won Park-Simon
No relevant relationships to disclose
Sven Mahner
No relevant relationships to disclose
Willibald Schroeder
No relevant relationships to disclose
Hans-Joachim Lueck
Consultant or Advisory Role - Celgene; Eisai; Novartis; Roche
Honoraria - Celgene; Eisai; Novartis; Roche
Martin Leonhard Heubner
No relevant relationships to disclose
Lars Christian Hanker
No relevant relationships to disclose
Falk Thiel
No relevant relationships to disclose
Felix Hilpert
No relevant relationships to disclose